
SI-BONE, Inc.
Nasdaq · Surgical & Medical Instruments & Apparatus
Company Overview
A concise company profile alongside the latest public filing activity.
SI-BONE, Inc. develops and markets minimally invasive surgical implants and instruments used to treat sacroiliac joint dysfunction and related conditions of the low back and pelvis.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| PISETSKY MICHAEL A.SVP, Ops & Adm/Chief Legal Ofr | Sell | $33K | 1,799at $18.14 | Oct 2, 2026 |
| Maheshwari AnshulChief Op & Financial Officer | Sell | $34K | 1,731at $19.50 | Oct 5, 2026 |
| PISETSKY MICHAEL A.SVP, Ops & Adm/Chief Legal Ofr | Sell | $24K | 1,300at $18.20 | Oct 2, 2026 |
| Maheshwari AnshulChief Op & Financial Officer | Sell | $28K | 1,560at $18.17 | Oct 2, 2026 |
| Maheshwari AnshulChief Op & Financial Officer | Sell | $32K | 1,758at $18.19 | Oct 2, 2026 |
| PISETSKY MICHAEL A.SVP, Ops & Adm/Chief Legal Ofr | Sell | $617 | 34at $18.14 | Oct 2, 2026 |
| DUNN JEFFREY WInsider | Sell | $26K | 1,367at $18.91 | Sep 1, 2026 |
| DUNN JEFFREY WInsider | Sell | $352K | 18,633at $18.91 | Sep 1, 2026 |
| FRANCIS LAURAChief Executive Officer | Sell | $79K | 3,923at $20.02 | Aug 21, 2026 |
| FRANCIS LAURAChief Executive Officer | Sell | $1.01M | 51,884at $19.46 | Aug 20, 2026 |
| Maheshwari AnshulChief Op & Financial Officer | Sell | $112K | 5,747at $19.55 | Aug 19, 2026 |
| Maheshwari AnshulChief Op & Financial Officer | Sell | $225K | 11,228at $20.02 | Aug 21, 2026 |
| DUNN JEFFREY WInsider | Sell | $369K | 20,000at $18.46 | Aug 3, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable SIBN activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.